emerald asset management  driven by research emerald is an asset management firm providing researchbased portfolio management we provide growthoriented and incomeproducing portfolios for institutions and individuals  previous next emerald’s outlook for energy deputy cio and portfolio manager david volpe provides emerald’s outlook for the energy sector as we head into the summer months you can read his report here active smallcap investing while active management has been under pressure emerald believes that small cap stocks – actively managed by experienced portfolio managers  can hold a key position in a plan sponsor’s allocation emerald’s small cap  portfolio managers explain why…… emerald value portfolio management team adds banking fund veteran steven russell steven e russell esq has been named associate portfolio manager emstone advisers marks milestone innovative enhanced fixed income strategies mark st year anniversary emerald adds to investment management team emerald adds experienced professional to growing investment management team emerald insights wit  wisdom –  q scg commentary why active smallcaps equity products learn more here income products learn more here asset allocation solutions etf learn more here get the emerald advantage our award winning team of analysts adheres to a proprietary  step research process conducting approx  company visits a year learn about our  step research process featured stories industry news  resources jul    – upcoming emerald events announced mark your calendars for two of emerald’s marquee annual events the  emerald foundation golf outing and the  emerald asset management groundhog day investment forum the emerald foundation golf outing and luncheon is the charity’s biggest fundraising event of the year this year’s outing will be held on monday october th the th annual … read more may   emerald advisers announces staff hiring promotions industry veteran steve hamilton joins emerald as two longtenured team members are promoted read the details here read more nov   emerald offices relocating emerald’s suburban philadelphia office is relocating to better serve our clients effective november th emerald’s new address will be emerald advisers inc  freedom business center drive suite  king of prussia pa  the main king of prussia office contact phone number remains  emerald’s midwestern regional office also recently relocated emerald’s new address … read more jul   emerald adds to investment management team emerald adds experienced professional to growing investment management team lancaster pa – emerald asset management inc an investment holding company with approximately  billion in assets has announced that industry veteran joseph hovorka has joined the emerald team emerald founder and ceo joseph e besecker announced that mr hovorka has joined subsidiary company emerald advisers … read more view more stories media library view previous stories view here groundhog day investment forum an investment industry tradition learn more the emerald foundation supporting communities learn more contact us client services email infoteamemeraldcom professionals login please fill out the form to log in to our emerald professionals area username password forgot password not a member sign up now emerald asset management  about us welcome to team emerald founded in  emerald provides equity and fixedincome portfolio management services to institutional investors and to individual investors via separate account management the emerald mutual funds the emerald direct lending marketplace lending funds and eagle etf portfolios research is the cornerstone of our equity investment strategies what we call “the emerald advantage”  what makes us different is our  member inhouse research team using a proprietary step research process dedicated to intense handson fundamental research specifically designed to identify unrecognized and underresearched growth companies  emerald also provides investors with fixed income separate account strategies using a combination of proprietary quantitative models and fundamental analysis emerald is headquartered in leola pennsylvania with additional offices in king of prussia pittsburgh and west conshohocken pennsylvania  and cleveland ohio  emerald managed approximately  billion as of march   parent company emerald asset management inc was founded in   subsidiary companies include emerald separate account management llc emerald advisers inc emerald mutual fund advisers trust emstone advisers llc and emerald direct lending advisers llc get the emerald advantage our team of analysts adheres to a proprietary  step research process conducting approx  meetings per year onsite at the company or offsite at conferences trade shows or other locations learn about our  step process media library view previous stories view here groundhog day investment forum an investment industry tradition learn more here the emerald foundation supporting communities learn more here professionals login please fill out the form to log in to our emerald professionals area username password forgot password not a member sign up now emerald asset management  contact us offices global headquarters  oregon pike leola pa    map king of prussia office  freedom business center drive suite  king of prussia pa    map pittsburgh office  kingston drive wilkins township pa    map midwest regional office  som center road suite  solon ohio    map call us client services and general information  emerald mutual funds shareholder services and transfer agent  email us general inquiries institutional client services groundhog day information employment inquiries complete  submit our contact form please fill out the form with your inquiry and a representative will be in touch with you shortly ​ name  email  message  please leave this field empty is fire hot or cold get the emerald advantage our team of analysts adheres to a proprietary  step research process conducting approx  meetings per year onsite at the company or offsite at conferences trade shows or other locations learn about our  step process media library view previous stories view here groundhog day investment forum an investment industry tradition learn more here the emerald foundation supporting communities learn more here professionals login please fill out the form to log in to our emerald professionals area username password forgot password not a member sign up now emerald asset management  investment strategies driven by research emerald research is the cornerstone of our equity investment process at emerald we firmly believe that the key to our investment success is to understand the companies we follow better than anyone else in researching each individual company or security emerald’s analysts utilize our proprietary ‐step research process learn more about our step process here emerald’s fixed income strategies utilize a conservative highquality disciplined approach focused on avoiding unnecessary risks and exploiting market inefficiencies learn more about our fixed income investment process and portfolio management team here equity separate accounts smallcap growth activelymanaged diversified smallcap growth portfolio usually holding approximately    stocks •overview •commentary midcap growth activelymanaged diversified midcap growth portfolio usually holding approximately  stocks •overview •commentary allcap growth growthoriented portfolio holding  stocks geared to longterm successful companies with no limitations regarding marketcap size •overview •commentary smallcap value activelymanaged concentrage smallcap value portfolio usually holding approximately    stocks •overview •commentary equity mutual funds emerald growth fund growthoriented mutual fund investing primarily in smallersized domestic companies information on soft close click here for mutual fund information click here for soft close info emerald banking  finance fund mutual fund investing primarily in banks and financial services companies click here for mutual fund information emerald insights fund mutual fund investing primarily in midcap companies click here for mutual fund information emerald smallcap value fund valueoriented mutual fund investing primarily in smallersized domestic companies click here for mutual fund information fixed income separate accounts core aggregate us treasury issues corporate bonds and mortgages the average maturity of a portfolio will range from  to  years minimum average portfolio quality aa •overview •commentary intermediate gov’t credit us treasury and agency issues corporate bonds and some mortgages the average maturity of a portfolio will range from  to  years minimum average portfolio quality aa •overview •commentary low duration us treasury and agency issues and some corporate bonds the average maturity of a portfolio will range from  to  years average portfolio quality aa •overview •commentary incomegenerating investment emerald direct lending advisers llc seeks to earn current income via active portfolio management of online marketplace lending loans and notes strategies available to accredited investors and public and corporate pension funds only •overview etfasset allocation strategies emerald eagle etf portfolio managed portfolio comprised of managerselected global etf’s and a “top holdings” basket of us stocks •overview get the emerald advantage our team of analysts adheres to a proprietary  step research process conducting approx  meetings per year onsite at the company or offsite at conferences trade shows or other locations learn about our  step process media library view previous stories view here groundhog day investment forum an investment industry tradition learn more here the emerald foundation supporting communities learn more here professionals login please fill out the form to log in to our emerald professionals area username password forgot password not a member sign up now emerald asset management  news jul    – upcoming emerald events announced mark your calendars for two of emerald’s marquee annual events the  emerald foundation golf outing and the  emerald asset management groundhog day investment forum the emerald foundation golf outing and luncheon is the charity’s biggest fundraising event of the year this year’s outing will be held on monday october th the th annual … read more may   q scg commentary optimism recedes market update the broad based postelection market optimism that dominated the fourth quarter receded somewhat during the first quarter as domestic economic growth decelerated the yield curve flattened and uncertainty grew regarding the timing and …read more here read more may   emerald’s outlook for energy deputy cio and portfolio manager david volpe provides emerald’s outlook for the energy sector as we head into the summer months you can read his report here read more may   emerald advisers announces staff hiring promotions industry veteran steve hamilton joins emerald as two longtenured team members are promoted read the details here read more nov   why active smallcaps while active management has been under pressure emerald believes that small cap stocks – actively managed by experienced portfolio managers – can hold a key position in a plan sponsor’s allocation emerald’s small cap portfolio managers explain why…… click here for the full report in pdf format   read more nov   emerald offices relocating emerald’s suburban philadelphia office is relocating to better serve our clients effective november th emerald’s new address will be emerald advisers inc  freedom business center drive suite  king of prussia pa  the main king of prussia office contact phone number remains  emerald’s midwestern regional office also recently relocated emerald’s new address … read more jul   emerald adds to investment management team emerald adds experienced professional to growing investment management team lancaster pa – emerald asset management inc an investment holding company with approximately  billion in assets has announced that industry veteran joseph hovorka has joined the emerald team emerald founder and ceo joseph e besecker announced that mr hovorka has joined subsidiary company emerald advisers … read more apr    upcoming emerald events announced mark your calendars for two of emerald’s marquee annual events the  emerald foundation golf outing and the  emerald asset management groundhog day investment forum the emerald foundation golf outing and luncheon is the charity’s biggest fundraising event of the year this year’s outing will be held on monday october th the th annual … read more feb   corporate leaders receive sixteenth annual emerald asset management “e awards” customers bancorp ollie’s bargain outlet and gsv capital executives recognized leola pa – the chief executive officers of customers bancorp nyse – cubi ollie’s bargain outlet holdings nasdaq olli and gsv capital nasdaq gsvc have been named as the recipients of the sixteenth annual “e awards” presented by emerald asset management at the rd annual … read more oct   emerald expands sales leadership team issue date october   lancaster pa – emerald asset management inc an investment holding company with approximately  billion in assets has announced that experienced sales and relationship management professional patrick j prato has joined the emerald team emerald founder and ceo joseph e besecker announced that mr prato has joined subsidiary company emerald … read more get the emerald advantage our team of analysts adheres to a proprietary  step research process conducting approx  meetings per year onsite at the company or offsite at conferences trade shows or other locations learn about our  step process media library view previous stories view here groundhog day investment forum an investment industry tradition learn more here the emerald foundation supporting communities learn more here professionals login please fill out the form to log in to our emerald professionals area username password forgot password not a member sign up now emerald asset management   step process in researching each individual company or security emerald’s analysts utilize this proprietary ‐step process  review sec filings press releases and news stories the process includes monitoring relevant media sources such as industry press financial press and popular press  meet with management meet with management across the organization in areas such as executive management marketing product development operations and finance the emerald research team conducts approximately  meetings per year onsite at the company or offsite at conferences trade shows or other locations  interview customers interview customers to determine  the critical factors driving their buy decision  what competitors or alternatives were considered  level of satisfaction with the quality of the product or service and  likelihood of generating repeat business  interview competitors interview competitors to determine their strengths and weaknesses as well the competitors perception of the strengths and weaknesses of the company  interview suppliers interview suppliers to determine their ability to supply the productsservices required by the company also assess the extent of potential supply chain bottlenecks  interview distributors interview distributors to determine potential issues and opportunities in the companys distribution channel such as inventory levels demand drivers and competitive pressures  develop financial and valuation models develop a financial model to analyze financial performance and estimate future cash flows earnings and financing needs use a valuation model to analyze relative and absolute valuation  review third party research review published research from sell‐side analysts and industry research firms to compare our data points and financial estimates also use third party research to assess securityspecific and industry‐specific sentiment  publish an internal research report publish an internal research report summarizing the companys business competitive advantages management strengthsweaknesses growth drivers and risks as well as stating investment conclusions and recommendations  communicate communicate communicate the entire research team meets formally twice per week and informally on an ongoing basis with the portfolio management team to discuss the fundamentals of all current and potential holdings internal discussions are held throughout the process media library view previous stories view here groundhog day investment forum an investment industry tradition learn more here the emerald foundation supporting communities learn more here professionals login please fill out the form to log in to our emerald professionals area username password forgot password not a member sign up now abbott laboratories nyseabt stock price news  analysis abbott laboratories company profile nyseabt company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about abbott laboratories nyseabt abbott laboratories is engaged in the discovery development manufacture and sale of a range of healthcare products the company operates through four segments established pharmaceutical products diagnostic products nutritional products and vascular products its established pharmaceutical products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the united states its diagnostic products include a range of diagnostic systems and tests its nutritional products include a range of pediatric and adult nutritional products its companys vascular products include a range of coronary endovascular vessel closure and structural heart devices for the treatment of vascular disease the company through st jude medical inc also offers products such as rhythm management products electrophysiology products heart failure related products vascular products structural heart products and neuromodulation products industry sector and symbol sector medical industry pharmaceuticals  nec subindustry health care equipment symbol nyseabt cusip  web wwwabbottcom capitalizationmarket cap  billionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio foreward pe ratio pe growth sales  book valueannual revenue  billionprice  sales book value  per shareprice  book dividendannual dividend dividend yield  profitabilityebidta  billionnet margins return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  million shsbeta short ratio    frequently asked questions for abbott laboratories nyseabt what is abbott laboratories stock symbol abbott laboratories trades on the new york stock exchange nyse under the ticker symbol abt how often does abbott laboratories pay dividends what is the dividend yield for abbott laboratories abbott laboratories declared a quarterly dividend on friday june th shareholders of record on friday july th will be paid a dividend of  per share on tuesday august th this represents a  dividend on an annualized basis and a yield of  the exdividend date of this dividend is wednesday july th view abbott laboratories dividend history how were abbott laboratories earnings last quarter abbott laboratories nyseabt issued its quarterly earnings results on thursday july th the company reported  earnings per share for the quarter beating the zacks consensus estimate of  by  the company earned  billion during the quarter compared to the consensus estimate of  billion abbott laboratories had a return on equity of  and a net margin of  the companys quarterly revenue was up  compared to the same quarter last year during the same quarter in the prior year the firm posted  earnings per share view abbott laboratories earnings history when will abbott laboratories make its next earnings announcement abbott laboratories is scheduled to release their next quarterly earnings announcement on tuesday october th  view earnings estimates for abbott laboratories what guidance has abbott laboratories issued on next quarters earnings abbott laboratories issued an update on its third quarter earnings guidance on thursday july th the company provided earnings per share eps guidance of  for the period compared to the thomson reuters consensus earnings per share estimate of  abbott laboratories also updated its fy guidance to  eps where is abbott laboratories stock going where will abbott laboratories stock price be in   brokers have issued month price objectives for abbott laboratories shares their forecasts range from  to  on average they expect abbott laboratories share price to reach  in the next twelve months view analyst ratings for abbott laboratories what are analysts saying about abbott laboratories stock here are some recent quotes from research analysts about abbott laboratories stock  according to zacks investment research for the majority of last one month abbott is trading above the broader medical products industry we are optimistic about the company’s strong and consistent epd and medical devices performance in the last reported first quarter overall the company stands to benefit from the ongoing integration and synergy achievement of st jude we are also looking forward to the company’s plans to focus on selling portfolio in core therapeutic areas recently abbott received ce mark for its tacticath sensor and confirm rx icm products which is quite encouraging the company also launched sciencebased nutrition drinks for better recovery from surgeries on the flip side abbott’s sluggish pediatric business in china continues to hamper growth management is also concerned about the ongoing economic problem in venezuela that is expected to remain unresolved in the coming quarters   jefferies group llc analysts commented investment summary we are reiterating our overweight rating for cori and we are raising our pt by  to  following the positive donepezil patch bioequivalence results progress in the development of a proprietary pipeline is key in our opinion to the performance of the shares successful development of patch formulations of donepezil aricept andor memantine namenda should position the company well to moreeffectively monetize the transdermal drug delivery platform in our opinion retention of meaningful commercialization rights could enable the company to turn the corner and pursue other opportunities more broadly in our opinion corplex donepezil pilot study shows bioequivalence management reported that the corplex donepezil pilot study met the fda statistical criteria for bioequivalence we note too that the patch was welltolerated with good skin and gi tolerability  who are some of abbott laboratories key competitors some companies that are related to abbott laboratories include merck  company mrk sanofi sny novo nordisk as nvo glaxosmithkline plc gsk eli lilly and company lly bristolmyers squibb company bmy astrazeneca plc azn glaxosmithkline plc gsk astrazeneca plc azn shire plc shpg shire plc shp teva pharmaceutical industries limited teva dr reddys laboratories ltd rdy valeant pharmaceuticals international vrx patheon nv pthn taro pharmaceutical industries taro catalent ctlt and akorn akrx who are abbott laboratories key executives abbott laboratories management team includes the folowing people miles d white chairman of the board chief executive officerbrian b yoor chief financial officer senior vice president  financemichael t rousseau president  cardiovascular and neuromodulationhubert l allen executive vice president general counsel secretarystephen r fussell executive vice president  human resourcesbrian j blaser executive vice president  diagnostics productsjohn m capek phd executive vice president  venturesrobert b ford executive vice president  medical devicesheather l mason executive vice president  nutritional productsroger bird senior vice president  us nutrition who owns abbott laboratories stock abbott laboratories stock is owned by a number of of retail and institutional investors top institutional investors include vontobel asset management inc  us bancorp de  rockefeller financial services inc  jarislowsky fraser ltd  nn investment partners holdings nv  and apg asset management nv  company insiders that own abbott laboratories stock include brian b yoor brian j blaser daniel gesua sive salvadori deepak s nath heather l mason hubert l allen jaime contreras jared watkin joseph j manning michael j warmuth miles d white robert b ford robert e funck roger bird sally e blount and stephen r fussell view institutional ownership trends for abbott laboratories who sold abbott laboratories stock who is selling abbott laboratories stock abbott laboratories stock was sold by a variety of institutional investors in the last quarter including dnb asset management as apg asset management nv bank of montreal can vontobel asset management inc hermes investment management ltd nn investment partners holdings nv rockefeller financial services inc and exxonmobil investment management inc tx company insiders that have sold abbott laboratories stock in the last year include daniel gesua sive salvadori deepak s nath heather l mason jared watkin joseph j manning michael j warmuth robert e funck roger bird and stephen r fussell view insider buying and selling for abbott laboratories who bought abbott laboratories stock who is buying abbott laboratories stock abbott laboratories stock was acquired by a variety of institutional investors in the last quarter including hexavest inc fisher asset management llc mn services vermogensbeheer bv national pension service pennsylvania trust co aperio group llc sit investment associates inc and jarislowsky fraser ltd company insiders that have bought abbott laboratories stock in the last two years include brian j blaser miles d white robert b ford and sally e blount view insider buying and selling for abbott laboratories how do i buy abbott laboratories stock shares of abbott laboratories can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is abbott laboratories stock price today one share of abbott laboratories stock can currently be purchased for approximately  marketbeat community rating for abbott laboratories nyse abtcommunity ranking   out of   outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about abbott laboratories and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for abbott laboratories nyseabt how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold ratings  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for abbott laboratories nyseabt show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsstifel nicolausreiterated ratingbuylowcowen and companyreiterated ratingoutperform  lowbmo capital marketsreiterated ratingholdlowmorgan stanleyreiterated ratingequal weightlowwells fargo  companyreiterated ratingoutperform  lowjefferies group llcreiterated ratingbuylowguggenheiminitiated coveragebuylowbtig researchinitiated coveragebuylowgoldman sachs group inc theinitiated coverageneutral  neutrallowroyal bank of canadareiterated ratingbuylowbarclays plcboost price targetoverweight  overweight  lowbank of america corporationreiterated ratingbuynadeutsche bank agreiterated ratingbuynaargusreiterated ratingbuynaedward jonesupgradehold  buynacredit suisse group agreiterated ratingbuynasp equity researchreiterated ratingholdnagabellireiterated ratingbuynapiper jaffray companiesdowngradeoverweight  neutralnafirst globaldowngradeoutperform  marketperformnaleerink swannboost price targetmarket perform  naraymond james financial inclower price targetoutperform  nawilliam blairdowngradeoutperform  market performnadata available from  forward earnings earnings history for abbott laboratories nyseabtearnings history by quarter for abbott laboratories nyse abtdatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsnaq  billion billionviewna billion billionviewnaq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenviewnaviewnaviewnaviewnaviewnaviewnaviewnaviewnadata available from  forward estimates earnings estimates for abbott laboratories nyseabt eps consensus estimate  eps consensus estimate quarternumber of estimateslow estimatehigh estimateaverage estimateq q q q q q q q data provided by zacks investment research dividends current dividend information for abbott laboratories nyseabtnext dividendannual dividenddividend yielddividend growth  year averagepayout ratio trailing  months of earnings  based on this years estimates based on next years estimatestrack record years of consecutive dividend growthdividend history by quarter for abbott laboratories nyse abtannouncedperiodamountyieldexdividend daterecord datepayable datequarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlydata available from  forward insider trades insider trading and institutional ownership history for abbott laboratories nyseabtinsider ownership percentage institutional ownership percentage insider trades by quarter for abbott laboratories nyseabttransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailsjared watkininsidersell  stephen r fussellinsidersell  roger birdinsidersell  joseph j manninginsidersell  michael j warmuthinsidersell  robert e funckvpsell  roger birdinsidersell  deepak s nathinsidersell  heather l masoninsidersell  brian j blaserinsiderbuy  robert b fordinsiderbuy  miles d whitechairmanbuy  sally e blountdirectorbuy  daniel gesua sive salvadorisvpsell  stephen r fussellinsidersell  michael j warmuthinsidersell  miles d whitechairmanbuy  robert e funckvpsell  hubert l allenevpsell  jared watkinsvpsell  brian b yoorcfosell  deepak s nathsvpsell  jaime contrerassvpsell  brian b yoorcfosell  deepak s nathsvpsell  robert b fordevpsell  robert e funckvpsell  jared watkinsvpsell  deepak s nathsvpsell  miles d whiteceosell  stephen r fussellevpsell  heather l masonevpsell  roger birdsvpsell  j scott whitesvpsell  jaime contrerassvpsell  john m capekevpsell  jaime contrerassvpsell  miles d whiteceosell  john landgrafevpsell  katherine doylesvpsell  robert funckvpsell  john landgrafevpsell  michael warmuthevpsell  jeanyves paveesvpsell  stephen fussellevpsell  jaime contrerassvpsell  heather l masonsvpsell  william a osborndirectorbuy  data available from  forward headlines headline trends for abbott laboratories nyseabt latest headlines for abbott laboratories nyseabt source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlineabbott labs abt pt raised to  at argus on q beat  fy raise positive view of growth prospects  streetinsidercomwwwstreetinsidercom  july  at  pmabbott labs abt pt raised to  at barclays on q beat  fy eps raise h outlook appears bright  streetinsidercomwwwstreetinsidercom  july  at  pmabbott laboratories abt buy rating reaffirmed at stifel nicolauswwwamericanbankingnewscom  july  at  pmtodays research reports on stocks to watch abbott laboratories and pfizer incfinanceyahoocom  july  at  pmcompany news for july  financeyahoocom  july  at  pmbehind the major drivers of jnj’s medical device growthfinanceyahoocom  july  at  pmabbott laboratories nyseabt price target raised to  at arguswwwamericanbankingnewscom  july  at  pmdeutsche bank ag increases abbott laboratories abt price target to wwwamericanbankingnewscom  july  at  pmzacks brokerages anticipate abbott laboratories nyseabt to announce  epswwwamericanbankingnewscom  july  at  amabbott q profit falls but results top view lifts  profit outlookwwwrttnewscom  july  at  amlabcorp lh q earnings is disappointment in the cardsfinanceyahoocom  july  at  pmabbott laboratories abt releases q earnings guidancewwwamericanbankingnewscom  july  at  pmabbott labs abt beats on q earnings and sales view up  nasdaqwwwnasdaqcom  july  at  pmabbott abt tops earnings estimates in q misses on salesfinanceyahoocom  july  at  pmus stockswall st flat as earnings from some big names disappointfinanceyahoocom  july  at  pmabbott zeros in on a year high after topping q sales profitsfinanceyahoocom  july  at  pmus stockswall st flat as consumer stocks weak earnings weighfinanceyahoocom  july  at  pmabbott ceo another alererelated divestiture coming soonfinanceyahoocom  july  at  pmabbott labs abt beats on q earnings and sales view upfinanceyahoocom  july  at  pmabbott profit forecast gets a lift from st jude integrationfinanceyahoocom  july  at  pmabbott tops street q forecastsfinanceyahoocom  july  at  pmus stockssp dow flat as retailers weigh nasdaq edges higherfinanceyahoocom  july  at  pmabbott laboratories abt releases earnings resultswwwamericanbankingnewscom  july  at  amabbott laboratories abt releases fy earnings guidancewwwamericanbankingnewscom  july  at  amwhat to watch for in abbotts q earnings  nasdaqwwwnasdaqcom  july  at  pmmedical product stocks earnings on jul  abt isrg  more  nasdaqwwwnasdaqcom  july  at  pmabbott laboratories nyseabt american express company   benzingawwwbenzingacom  july  at  pmquidel diversifies with aleres triage assets  thestreetcomwwwthestreetcom  july  at  pmquidel diversifies with aleres triage assetsfinanceyahoocom  july  at  pmrisk arbitrage today  ma deals that had price cuts with a little meat left on the boneseekingalphacom  july  at  pmabbotts tarnished deal sparkles for anotherfinanceyahoocom  july  at  pmcan abbott laboratories abt pull a surprise in q earnings  nasdaqwwwnasdaqcom  july  at  amcan abbott laboratories abt pull a surprise in q earningsfinanceyahoocom  july  at  pmearnings roundup jnj ibm and lmt report q results tomorrow  benzingawwwbenzingacom  july  at  pmscience sugar substitute effects not so sweetfinanceyahoocom  july  at  pmcorporate america is about to unleash great earnings reports hopefully week ahead  thestreetcomwwwthestreetcom  july  at  amabbott labs abt pt raised to  at cowen refining sales   streetinsidercomwwwstreetinsidercom  july  at  pmabt wall street analysts’ recommendations ahead of q earningsfinanceyahoocom  july  at  pmwill abbott laboratories beat analyst revenue estimates in qfinanceyahoocom  july  at  pmwhat to expect from abbott laboratories’ q earningsfinanceyahoocom  july  at  pmcowen and company reiterates outperform rating for abbott laboratories abtwwwamericanbankingnewscom  july  at  pmtraders buy large volume of abbott laboratories call options nyseabtwwwamericanbankingnewscom  july  at  amabbott teams up with bigfoot bio in diabetes management  seeking alphaseekingalphacom  july  at  amabbott novartis show promise amid healthcare decline tiffany lands much needed boost icymi thurs  thestreetcomwwwthestreetcom  july  at  amabbott laboratories abt set to announce quarterly earnings on thursdaywwwamericanbankingnewscom  july  at  pmabbott and bigfoot biomedical announce collaboration to develop breakthrough diabetes technologiesfinanceyahoocom  july  at  pmabbott laboratories is set for another breakoutfinanceyahoocom  july  at  pmmajor transformations for abbott are paying offseekingalphacom  july  at  pmedwards emerges strong on fda nods international prospect  nasdaqwwwnasdaqcom  july  at  pmlabcorp diagnostics strong on novant health deal extensionfinanceyahoocom  july  at  pm social chart abbott laboratories abt chart for saturday july   this page was last updated on  by marketbeatcom staff   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied emerald advisers incpa institutional portfolio  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  ownership  insider trades  institutional portfolio emerald advisers incpa  oregon pike leola pennsylvania    report date  position statistics total positions  new positions  increased positions  decreased positions  positions with activity  sold out positions  total mkt value in  millions  institutional holdings information is filed by major institutions on form f with the securities and exchange commission sector weighting energy  basic materials  industrials  consumer cyclicals  consumer noncyclicals  financials  healthcare  technology  telecommunication services  utilities total positions new increased decreased activity sold out  positions as of  company class value of shares s ▼ change in value s change  shares held veeva sys inc cl a com     taketwo interactive software com     lendingtree inc new com     microsemi corp com     bank of the ozarks inc com     apogee enterprises inc com     epam sys inc com     dycom inds inc com     installed bldg prods inc com     proofpoint inc com     lumentum hldgs inc com     trex co inc com     vonage hldgs corp com     nutri sys inc new com     mercury sys inc com     puma biotechnology inc com   new  sarepta therapeutics inc com     bofi hldg inc com     microstrategy inc cl a new     x inc new com      first previousnext last  latest news headlines pcm to release q  results july   pm et   globenewswire exclusiveus weighs financial sanctions to hit venezuelas oil revenue  sources pm et   reuters deutsche bank jpmorgan to pay  mln to end yen libor cases in us pm et   reuters the dixie group to broadcast its  second quarter earnings conference call live on the internet pm et   globenewswire us fines american delta frontier for consumer rule violations pm et   reuters view all latest headlines closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex emerald advisers inc  leola  pa  company information products resources my account talk to a db advisor  business directory pa leola investment advice investment advice emerald advisers inc e emerald advisers inc claim this business  oregon pike leola pa  get directions   business info founded  incorporated pa annual revenue  employee count  industries investment advice contacts joseph e bessecker contact business your email address subject message send message company summary since  the company has been providing investment advice verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   e view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved emerald advisers inc private company information  bloomberg july    pm et capital markets company overview of emerald advisers inc snapshot people company overview emerald advisers inc is a privately owned investment manager the firm provides its services to state or municipal government entities high net worth individuals pension and profit sharing plans charitable organizations and corporations it manages separate clientfocused equity portfolios the firm also manages equity mutual funds for its clients it invests in the public equity markets of the united states the firm invests in growth stocks of smallcap midcap and largecap companies it employs a combination of quantitative and fundamental analysis with bottomup stock picking approach to create its portfolio the firm benchmarks the performance of its portfolio against the russe emerald advisers inc is a privately owned investment manager the firm provides its services to state or municipal government entities high net worth individuals pension and profit sharing plans charitable organizations and corporations it manages separate clientfocused equity portfolios the firm also manages equity mutual funds for its clients it invests in the public equity markets of the united states the firm invests in growth stocks of smallcap midcap and largecap companies it employs a combination of quantitative and fundamental analysis with bottomup stock picking approach to create its portfolio the firm benchmarks the performance of its portfolio against the russell  growth index and russell mid cap growth index it conducts inhouse research to make its investments the firm invests in financial services sector the firm is based in leola pennsylvania with additional offices in king of prussia pennsylvania wilkins township pennsylvania and solon ohio emerald advisers inc operates as a subsidiary of emerald asset management inc detailed description  oregon pikeleola pa united statesfounded in  phone  fax  wwwteamemeraldcomservicesequityphp key executives for emerald advisers inc mr kenneth george mertz ii cfa president chief investment officer and director mr scott l rehr chief operating officer age  mr mitchell w krahe jd esq vice president and general counsel mr thomas a dattilo executive vice president mr daniel webster moyer iv executive vice president and secretary compensation as of fiscal year  emerald advisers inc key developments emerald advisers inc announces executive appointment and promotions may   emerald asset management inc has announced that subsidiary company emerald advisers inc has hired and promoted key staff members as its advisory business continues to grow stephen d hamilton has joined the senior staff as vice president – portfolio specialist he is responsible for maintaining and expanding emerald’s extensive relationships with consultants and institutions working in collaboration with emerald’s portfolio management sales and client services teams mr hamilton has over eighteen years’ experience in the institutional investment industry most recently as a vice president with franklin templeton investments previously he was vice president institutional sales  consultant relations for delaware investments where he worked for sixteen years in addition emerald advisers has promoted two key longterm employees audrey ly has been promoted to assistant vice president – client services and julie clawser has been promoted to the new position of senior executive assistant – investments ms ly has been with emerald for  years and directs emerald’s client and marketing materials fulfillment and informational request responsibilities ms clawser has been with emerald for  years and coordinates the portfolio management and research teams’ administrative and noninvestment associated tasks emerald advisers inc appoints steven e russell as associate portfolio manager for its value strategy and related small cap and smallmid cap value products nov   emerald advisers inc announced that steven e russell esq has been named associate portfolio manager for emerald’s value strategy and related small cap and smallmid cap value products he joins emerald’s rick giesen and ori elan who have managed the strategy since its inception in  russell first joined emerald’s research analyst team in  and has over twenty years of industry and investment experience he serves as a comanager of the emerald banking  finance fund and as a portfolio manager of an affiliated emerald adviser’s marketplace lending strategies emerald advisers inc appoints joseph hovorka as senior research analyst – associate portfolio manager jul   emerald asset management inc has announced that joseph hovorka has joined the emerald team emerald founder and ceo joseph e besecker announced that mr hovorka has joined subsidiary company emerald advisers inc as senior research analyst – associate portfolio manager he will join the firm’s midcap growth strategy portfolio management team and provide research analysis to all emerald portfolio management teams focusing on consumer discretionary companies mr hovorka will be based primarily in emerald’s cleveland oh office prior to joining emerald mr hovorka most recently served as managing director of equity research at raymond james while at raymond james he covered the leisure and entertainment industries and was part of the team that took several companies public he has over twenty years of experience in the investment industry similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states bertelsmann ag europe the advertising council inc united states rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact emerald advisers inc please visit wwwteamemeraldcomservicesequityphp company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close ﻿ suntrust banks inc reiterates “buy” rating for alexion pharmaceuticals inc alxn  chaffey breeze daily ratings  news for alexion pharmaceuticals inc complete the form below to receive the latest headlines and analysts recommendationsfor alexion pharmaceuticals inc with our free daily email newsletter follow chaffeybreeze recent posts smith  nephew snats inc snn shares sold by pnc financial services group inc paychex inc payx shares bought by legal  general group plc pnc financial services group inc maintains position in brookfield renewable partners lp bep copart inc cprt stake increased by pnc financial services group inc legal  general group plc takes position in amn healthcare services inc amn legal  general group plc buys  shares of esterline technologies corporation esl boyd gaming corporation byd position increased by legal  general group plc legal  general group plc buys  shares of tyler technologies inc tyl eaton corporation plc etn shares sold by meeder asset management inc marshall wace asia ltd takes position in polaris industries inc pii bp plc bp stake maintained by princeton portfolio strategies group llc powershares qqq trust series  qqq shares bought by captrust financial advisors ngam advisors lp lowers position in allstate corporation the all thrivent financial for lutherans purchases  shares of wp carey inc wpc seaward management limited partnership has  stake in ingredion incorporated nyseingr head to head contrast portland general electric por vs wec energy group wec critical analysis devry education group atge vs strayer education nasdaqstra headtohead analysis concordia international corp cxrx vs tetraphase pharmaceuticals ttph tangoe tngo  iron mountain irm headtohead survey comparing biglari holdings bh  ruby tuesday rt suntrust banks inc reiterates “buy” rating for alexion pharmaceuticals inc alxn posted by charlotte bryant on jul th   no comments alexion pharmaceuticals inc nasdaqalxn‘s stock had its “buy” rating reissued by equities research analysts at suntrust banks inc in a research report issued on friday they presently have a  price objective on the biopharmaceutical company’s stock suntrust banks inc’s price target would suggest a potential upside of  from the stock’s current price several other research analysts have also weighed in on alxn ubs ag assumed coverage on shares of alexion pharmaceuticals in a research note on wednesday march th they set a “buy” rating and a  target price for the company jefferies group llc set a  price target on shares of alexion pharmaceuticals and gave the stock a “hold” rating in a research report on thursday june th bidaskclub raised shares of alexion pharmaceuticals from a “sell” rating to a “hold” rating in a research report on tuesday june th j p morgan chase  co reissued a “hold” rating on shares of alexion pharmaceuticals in a research report on wednesday june th finally leerink swann reissued an “outperform” rating on shares of alexion pharmaceuticals in a research report on thursday june nd eight analysts have rated the stock with a hold rating eighteen have given a buy rating and one has issued a strong buy rating to the company the stock currently has a consensus rating of “buy” and an average price target of  get alexion pharmaceuticals inc alerts shares of alexion pharmaceuticals nasdaq alxn opened at  on friday the company has a market cap of  billion a pricetoearnings ratio of  and a beta of  the stock has a  day moving average of  and a  day moving average of  alexion pharmaceuticals has a month low of  and a month high of  alexion pharmaceuticals nasdaqalxn last announced its earnings results on thursday april th the biopharmaceutical company reported  earnings per share for the quarter topping the thomson reuters’ consensus estimate of  by  the company had revenue of  million during the quarter compared to analyst estimates of  million alexion pharmaceuticals had a net margin of  and a return on equity of  alexion pharmaceuticals’s revenue was up  compared to the same quarter last year during the same quarter last year the firm posted  earnings per share equities research analysts predict that alexion pharmaceuticals will post  earnings per share for the current fiscal year copyright violation notice “suntrust banks inc reiterates “buy” rating for alexion pharmaceuticals inc alxn” was originally reported by chaffey breeze and is owned by of chaffey breeze if you are viewing this piece of content on another domain it was illegally stolen and republished in violation of us  international copyright legislation the correct version of this piece of content can be viewed at httpswwwchaffeybreezecomsuntrustbanksincreiteratesbuyratingforalexionpharmaceuticalsincalxnhtml in other alexion pharmaceuticals news ceo ludwig hantson bought  shares of the stock in a transaction dated wednesday june th the shares were acquired at an average cost of  per share for a total transaction of  following the completion of the transaction the chief executive officer now owns  shares in the company valued at approximately  the transaction was disclosed in a document filed with the sec which can be accessed through this hyperlink also director bros advisors lp baker bought  shares of the stock in a transaction dated wednesday june th the shares were acquired at an average price of  per share for a total transaction of  the disclosure for this purchase can be found here in the last three months insiders have acquired  shares of company stock worth   of the stock is owned by corporate insiders several institutional investors have recently made changes to their positions in the company crestpoint capital management llc acquired a new position in shares of alexion pharmaceuticals during the second quarter worth about  oregon public employees retirement fund raised its position in shares of alexion pharmaceuticals by  in the second quarter oregon public employees retirement fund now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period eqis capital management inc raised its position in shares of alexion pharmaceuticals by  in the second quarter eqis capital management inc now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period mn services vermogensbeheer bv raised its position in shares of alexion pharmaceuticals by  in the second quarter mn services vermogensbeheer bv now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period finally national pension service raised its position in shares of alexion pharmaceuticals by  in the second quarter national pension service now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period institutional investors and hedge funds own  of the company’s stock alexion pharmaceuticals company profile alexion pharmaceuticals inc is a biopharmaceutical company the company is focused on the development and commercialization of therapeutic products the company’s products include soliris eculizumab strensiq asfotase alfa and kanuma sebelipase alfa the company’s clinical development programs include soliris eculizumab cpmp alxn sbc alxn iv and alxn subcutaneous receive news  ratings for alexion pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for alexion pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website emerald advisers inc  wealthminder emerald advisers inc emerald advisers inc crd  is a financial advisory firm headquartered in leola pa they manage  in  accounts and serve the financial needs of clients across  states or territories current firm details emerald advisers inc  oregon pike leola pa   httpwwwteamemeraldcom httpwwwteamemeraldcom by the numbers total assets under management  million total number of accounts  accounts average account value  compensation options a percentage of assets under your management advisory services offered portfolio management for individuals andor small businesses portfolio management for businesses other than small businesses or institutional clients types of clients registered states registered investment advisor advisors affiliated with a ria are permitted to work with up to five clients in nearlyall states without explicit registration the map below shows states where this firm has explicit registration only ca de ga md nj pa tx financial advisors at emerald advisers inc showing    of  top financial advisors  joseph w garner crd   oregon pike suite  lancaster pa   wealthminder score joseph garner crd  is an investment advisor representative working at emerald advisers inc in lancaster pa and has over  years of experience in the finance industry  stacey l sears crd   oregon pike suite  lancaster pa   wealthminder score stacey sears crd  is an investment advisor representative working at emerald advisers inc in lancaster pa and has over  years of experience in the finance industry  kenneth g mertz crd   oregon pike suite  lancaster pa   wealthminder score kenneth mertz crd  is an investment advisor representative working at emerald advisers inc in lancaster pa and has  year of experience in the finance industry our primary data source is public filings of form adv as published by the securities and exchange commission sec and made available in accordance with the freedom of information act foia supplementary information may be provided by listed advisors or their representatives because many firms provide a variety of products or services an individual may or may not be registered to operate under all services provided by the firmdo not rely solely on the information on this page the information may be inaccurate incomplete or outdated for the most accurate and uptodate information please search for the firm or individual on the sec site at httpwwwadviserinfosecgoviapdcontentsearchiapdsearchaspx ready to hire a financial advisor get competitive proposals from multiple advisors request proposals timeout you have been idle and will be logged out in seconds stay logged in log out now emerald advisers inc  oregon pike leola pa consultantsbusiness nec  mapquest emerald advisers inc  oregon pike leola pa  reviews   website menu  reservations make reservations order online tickets tickets see availability nearby directions  sponsored topics see a problem let us know legal help emerald asset management  driven by research emerald is an asset management firm providing researchbased portfolio management we provide growthoriented and incomeproducing portfolios for institutions and individuals  previous next emerald’s outlook for energy deputy cio and portfolio manager david volpe provides emerald’s outlook for the energy sector as we head into the summer months you can read his report here active smallcap investing while active management has been under pressure emerald believes that small cap stocks – actively managed by experienced portfolio managers  can hold a key position in a plan sponsor’s allocation emerald’s small cap  portfolio managers explain why…… emerald value portfolio management team adds banking fund veteran steven russell steven e russell esq has been named associate portfolio manager emstone advisers marks milestone innovative enhanced fixed income strategies mark st year anniversary emerald adds to investment management team emerald adds experienced professional to growing investment management team emerald insights wit  wisdom –  q scg commentary why active smallcaps equity products learn more here income products learn more here asset allocation solutions etf learn more here get the emerald advantage our award winning team of analysts adheres to a proprietary  step research process conducting approx  company visits a year learn about our  step research process featured stories industry news  resources jul    – upcoming emerald events announced mark your calendars for two of emerald’s marquee annual events the  emerald foundation golf outing and the  emerald asset management groundhog day investment forum the emerald foundation golf outing and luncheon is the charity’s biggest fundraising event of the year this year’s outing will be held on monday october th the th annual … read more may   emerald advisers announces staff hiring promotions industry veteran steve hamilton joins emerald as two longtenured team members are promoted read the details here read more nov   emerald offices relocating emerald’s suburban philadelphia office is relocating to better serve our clients effective november th emerald’s new address will be emerald advisers inc  freedom business center drive suite  king of prussia pa  the main king of prussia office contact phone number remains  emerald’s midwestern regional office also recently relocated emerald’s new address … read more jul   emerald adds to investment management team emerald adds experienced professional to growing investment management team lancaster pa – emerald asset management inc an investment holding company with approximately  billion in assets has announced that industry veteran joseph hovorka has joined the emerald team emerald founder and ceo joseph e besecker announced that mr hovorka has joined subsidiary company emerald advisers … read more view more stories media library view previous stories view here groundhog day investment forum an investment industry tradition learn more the emerald foundation supporting communities learn more contact us client services email infoteamemeraldcom professionals login please fill out the form to log in to our emerald professionals area username password forgot password not a member sign up now bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one